Latest filing published 13 Apr 2020 for Keros Therapeutics, Inc., €1.8M.
Filing timeline
BuySaleInsider track record
No signal scores available.
Closed purchases
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- +123.6%Entry US$27.49 · Close at T+365 US$61.47
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Arkin Bio Ventures Limited Partnership: trading record in brief
This profile gathers the share dealings of Arkin Bio Ventures Limited Partnership in Keros Therapeutics, Inc. We count 4 filings, every one of them for a trade on 13 April 2020.
On the market, this insider has only ever bought: 1 purchase, €1.8M in total. Unlike grants, an open-market purchase is paid for by the insider, at the market price.
On 13 April 2020 came the latest disclosure, an open-market purchase for €1.8M in Keros Therapeutics, Inc. Publication is fast: at least half of the trades appear on SEC (Form 4) on the same day. US insiders must file a Form 4 within two business days of a trade. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Arkin Bio Ventures Limited Partnership
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 120,000 shares@ US$16.00100.0% of flowCommon StockSEC:0001178913-20-001105:3Canonical exit: 12 Jul 2020 (T+90)
- 1,382,295 sharesCommon StockSEC:0001178913-20-001105:0
- 343,270 sharesCommon StockSEC:0001178913-20-001105:1
- 167,537 sharesCommon StockSEC:0001178913-20-001105:2
4 of 4 declarations
